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Sesquiterpenes are natural compounds which can be found in alternative 
medicines or food supplements. However, not all representatives have a beneficial effect 
on health. Indeed, sufficient attention should be paid to the evidence of serious toxicities 
and side effects. The aim of this diploma thesis was to find out, whether acyclic 
sesquiterpenes cis-nerolidol (cNER), trans-nerolidol (tNER) and farnesol (FAR) possess 
a modulatory effect on protein and gene expression of selected phase 1 drug-metabolizing 
enzymes - four cytochrome P450 (CYP) isoforms, namely CYP1A2, CYP2B6, CYP2C 
and CYP3A4, carbonyl reductase 1 (CBR1) and aldo-ketoreductase 1C3 (AKR1C3). The 
ultra-thin liver slices from five patients of both sexes aged 45 to 81 years were used as 
studied material. The liver slices were incubated with studied compounds at a 
concentration of 10 µM (in one patient, cNER and tNER also at 30 µM concentration) at 
37 °C for 24 hours. The protein expression was determined by electrophoresis with 
Western blot and relative mRNA expression by quantitative polymerase chain reaction 
(qPCR).  
The FAR and tNER at 10 µM concentration markedly inhibited CBR1 protein 
expression in the one patient. In other patient, cNER (10 and 30 μM) and tNER (30 μM) 
decreased AKR1C3 protein expression. The strongest effect on mRNA expression 
expressed tNER, which 2.1-times induced CYP1A2 expression in patient No. 9. 
Furthermore, FAR and tNER significantly reduced mRNA expression of all followed 
enzymes in one patient, at whom cNER at the same time significantly increased CYP2B6 
mRNA expression. Beside inhibitory effects, FAR cause increase in CYP1A2 and 
CYP2B6 expression in two patients.  The results pointed out interindividual variability 
among individuals. In conclusion, these acyclic sesquiterpenes at concentrations 
commonly available in the diet are unlikely to markedly affect the biotransformation of 
co-administered drugs. 
